Cargando…
Heterogeneity of asthma–COPD overlap syndrome
Many patients suffering from asthma or COPD have overlapping features of both diseases. However, a phenotypical approach for evaluating asthma–COPD overlap syndrome (ACOS) has not been established. In this report, we examined the phenotypes in patients with ACOS. Patients diagnosed with ACOS between...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327913/ https://www.ncbi.nlm.nih.gov/pubmed/28260876 http://dx.doi.org/10.2147/COPD.S130943 |
_version_ | 1782510819934732288 |
---|---|
author | Joo, Hyonsoo Han, Deokjae Lee, Jae Ha Rhee, Chin Kook |
author_facet | Joo, Hyonsoo Han, Deokjae Lee, Jae Ha Rhee, Chin Kook |
author_sort | Joo, Hyonsoo |
collection | PubMed |
description | Many patients suffering from asthma or COPD have overlapping features of both diseases. However, a phenotypical approach for evaluating asthma–COPD overlap syndrome (ACOS) has not been established. In this report, we examined the phenotypes in patients with ACOS. Patients diagnosed with ACOS between 2011 and 2015 were identified and classified into four phenotype groups. Group A was composed of patients who smoked <10 pack years and had blood eosinophil counts ≥300. Group B was composed of patients who smoked <10 pack years and had blood eosinophil counts <300. Group C was composed of patients who smoked ≥10 pack years and had blood eosinophil counts ≥300. Group D was composed of patients who smoked <10 pack years and had blood eosinophil counts <300. Clinical characteristics were analyzed and compared among groups. Comparisons were made among 103 ACOS patients. Patients in group D were oldest, while patients in group A were youngest. There were relatively more female patients in groups A and B; the majority of patients in groups C and D were male. The degree of airflow obstruction was most severe in group C. The rate of being free of severe exacerbation was significantly lower in group C than in the other groups. In this study, each ACOS phenotype showed different characteristics. The proportion of patients free of severe exacerbation differed significantly among groups. At this time, further studies on the phenotypes of ACOS are required. |
format | Online Article Text |
id | pubmed-5327913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-53279132017-03-03 Heterogeneity of asthma–COPD overlap syndrome Joo, Hyonsoo Han, Deokjae Lee, Jae Ha Rhee, Chin Kook Int J Chron Obstruct Pulmon Dis Original Research Many patients suffering from asthma or COPD have overlapping features of both diseases. However, a phenotypical approach for evaluating asthma–COPD overlap syndrome (ACOS) has not been established. In this report, we examined the phenotypes in patients with ACOS. Patients diagnosed with ACOS between 2011 and 2015 were identified and classified into four phenotype groups. Group A was composed of patients who smoked <10 pack years and had blood eosinophil counts ≥300. Group B was composed of patients who smoked <10 pack years and had blood eosinophil counts <300. Group C was composed of patients who smoked ≥10 pack years and had blood eosinophil counts ≥300. Group D was composed of patients who smoked <10 pack years and had blood eosinophil counts <300. Clinical characteristics were analyzed and compared among groups. Comparisons were made among 103 ACOS patients. Patients in group D were oldest, while patients in group A were youngest. There were relatively more female patients in groups A and B; the majority of patients in groups C and D were male. The degree of airflow obstruction was most severe in group C. The rate of being free of severe exacerbation was significantly lower in group C than in the other groups. In this study, each ACOS phenotype showed different characteristics. The proportion of patients free of severe exacerbation differed significantly among groups. At this time, further studies on the phenotypes of ACOS are required. Dove Medical Press 2017-02-22 /pmc/articles/PMC5327913/ /pubmed/28260876 http://dx.doi.org/10.2147/COPD.S130943 Text en © 2017 Joo et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Joo, Hyonsoo Han, Deokjae Lee, Jae Ha Rhee, Chin Kook Heterogeneity of asthma–COPD overlap syndrome |
title | Heterogeneity of asthma–COPD overlap syndrome |
title_full | Heterogeneity of asthma–COPD overlap syndrome |
title_fullStr | Heterogeneity of asthma–COPD overlap syndrome |
title_full_unstemmed | Heterogeneity of asthma–COPD overlap syndrome |
title_short | Heterogeneity of asthma–COPD overlap syndrome |
title_sort | heterogeneity of asthma–copd overlap syndrome |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327913/ https://www.ncbi.nlm.nih.gov/pubmed/28260876 http://dx.doi.org/10.2147/COPD.S130943 |
work_keys_str_mv | AT joohyonsoo heterogeneityofasthmacopdoverlapsyndrome AT handeokjae heterogeneityofasthmacopdoverlapsyndrome AT leejaeha heterogeneityofasthmacopdoverlapsyndrome AT rheechinkook heterogeneityofasthmacopdoverlapsyndrome |